SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
340B: Biologic/Small molecule drug negotiation eligibility within HR 7174/S.832 EPIC Act; CDC Type 1 Diabetes Awareness and Education within LHHS appropriations; Clinical Trial Diversity; Clinical Trial Data Requirements in AG Appropriations Bill; Copay Accumulators; COPD Education and Awareness within LHHS appropriations; COPD Research Funding within LHHS appropriations; Delinking; Drug Pricing - General; Drug Price Negotiations within Inflation Reduction Act; Drug Pricing- General Issues; FDA Drug Development; FDA Issues - General; Issues related to HR 1 One Big Beautiful Bill; HR 6423/S864 HELP Copays Act; HR 2880: Protecting Patients Against PBM Abuses Act; HR 5376:Inflation Reduction Act; HRSA - Type 1 Diabetes Screening within LHHS appropriations; Influenza Vaccines; Insurance Design/Utilization Management; Intellectual Property; International Reference Pricing; Most Favored Nation; Orphan Drug Negotiation within HR 5539/S 3131 Orphan Cures Act; Out of Pocket Cap; Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization; Patient Experience/Patient Focused Drug Development within the FDA/AG Appropriations; Pharmacy Benefit Managers (PBM) Reform; Rare Pediatric Priority Review Voucher Program Reauthorization within HR 7834; Rebate Pass Through; Respiratory Syncytial Virus (RSV) Access; Routine Immunization Rates; S. 864 HELP Copays Act: S. 1339 (118th): PBM Reform Act; S. 1375: HELP Copays Act; S. 1542 (118th) DRUG Act; S. 2027: Prescription Information Modernization Act; S.4504 / HR 8698 (118th): SCREEN for Type 1 Diabetes Act; Supply Chain; Tax Credits; Transplant; Vaccine Injury Compensation Program; Vaccines-General Issues.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| EMILY MICHAEL | — |
| KATIE OPPENHEIM | — |
Medicare/Medicaid MMM
340B; Medicare Negotiation, and Most Favored Nation.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| EMILY MICHAEL | — |
| KATIE OPPENHEIM | — |
Trade (domestic/foreign) TRD
COINS Act Implementation; HR 9102 BINSA Bill; Supply Chain Issues; and Importation issues.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| KATIE OPPENHEIM | — |
Taxation/Internal Revenue Code TAX
Supply Chain issues; TRIP Waivers; and Vaccine Injury Compensation Program.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| EMILY MICHAEL | — |
| KATIE OPPENHEIM | — |
Copyright/Patent/Trademark CPT
S. 43: Skinny Labels, Big Savings Act; S. 2276 ETHIC Act; and Intellectual Property.
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CLAIRE WILLIS BRANDEWIE | — |
| JENNIFER DALE | — |
| EMILY MICHAEL | — |
| KATIE OPPENHEIM | — |
Manufacturing MAN
Insulin; Pharmacy Benefits Managers (PBMs); Taxes- General Issues; China issues; Type 1 Diabetes Screening; and Vaccines - General Issues
Foreign entity interest: Sanofi US Services Inc is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MORGAN BRADLEY-JONES | — |
| KATIE OPPENHEIM | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.